Ex vivo liver machine perfusion for decreasing 'Time-To-Transplant'

Image
Image

In Germany, there is a critical shortage of donor organs, and the liver transplantation waiting list is characterized by a high mortality rate. The ExTra study – “Pilot, open-label, prospective, randomized, multicenter trial on quality assessment of declined liver grafts by normothermic ex vivo machine perfusion to reduce time to transplantation” – therefore aims to shorten the waiting time for liver transplantation by assessing the quality of declined liver grafts through ex vivo machine perfusion.

© 2025 Prof. Dr. Nathanael Raschzok | Charité – Universitätsmedizin Berlin | Disclaimer

This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purpose illustrated in the Disclaimer. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.